ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,167Medicare Part D Prescriptions Filled, Including Refills

Rank: 398 out of 3001

$486K Total Retail Price of All Prescriptions

Rank: 682 out of 3001

553 Patients Receiving at Least One Drug in Part D
45%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 553 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 553 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 4,806 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
AMLODIPINE BESYLATE 566 291 1 5
SIMVASTATIN 472 289 2 1
LISINOPRIL 441 210 3 2
OMEPRAZOLE 396 261 4 4
TRAMADOL HCL 392 127 5 17
METFORMIN HCL 374 199 6 9
NEXIUM 364 266 7 23
OXYCODONE-ACETAMINOPHEN 336 133 S2 8 32
PROAIR HFA 300 114 9 30
IBUPROFEN 264 134 10 74
HYDROCODONE-ACETAMINOPHEN 215 77 S3 11 7
HYDROCHLOROTHIAZIDE 205 87 12 10
MELOXICAM 167 100 13 34
POTASSIUM CHLORIDE 157 41 14 15
FUROSEMIDE 155 54 15 6
GABAPENTIN 148 52 16 14
TAMSULOSIN HCL 143 122 17 29
ATENOLOL 124 74 18 18
METOPROLOL TARTRATE 121 37 19 8
GLYBURIDE 119 54 R 20 62
CLONIDINE HCL 113 39 21 64
CELEBREX 109 91 22 89
CARVEDILOL 100 45 23 25
TRAZODONE HCL 100 35 23 37
ADVAIR DISKUS 98 52 25 58
TRIAMTERENE-HCTZ 87 52 26 48
LEVOTHYROXINE SODIUM 82 47 27 3
KLOR-CON M10 79 40 28 138
AZITHROMYCIN 77 40 29 36
WARFARIN SODIUM 77 0 29 12
RANITIDINE HCL 74 44 31 41
NAPROXEN 74 44 31 84
FLUOCINONIDE 70 32 33 282
ATORVASTATIN CALCIUM 67 27 34 11
ZOLPIDEM TARTRATE 65 17 35 24
KLOR-CON 10 60 37 36 160
DIOVAN 59 26 37 50
LANSOPRAZOLE 59 28 37 140
ONGLYZA 58 22 39 211
FLUCONAZOLE 57 0 40 194
AMITRIPTYLINE HCL 57 29 R 40 85
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 31 42 22
KLOR-CON M20 54 25 43 52
ALLOPURINOL 52 14 44 35
CYCLOBENZAPRINE HCL 51 0 R 45 73
ALENDRONATE SODIUM 51 33 45 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.